Ko is a professor of clinical medicine and interim division chief of oncology in the division of hematology/oncology at the University of California, San Francisco. He is also a member of the HemOnc Today editorial board.
Choose a Section
Most recent by Andrew H. Ko, MD
We’re sorry, but an unexpected error has occurred.